Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Enlicitide Decanoate (MK-0616) in Pediatric Heterozygous Familial Hypercholesterolemia
CTR20254984Phase 3Active
- Sponsor
- 不适用/ 默沙东研发（中国）有限公司
- Start
- Sep 2025
- Modality
- Cyclic Peptides → Modified Peptides → Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of enlicitide in familial hypercholesterolemia (FH), sponsored by 不适用/ 默沙东研发（中国）有限公司. Started Sep 2025; status: active.
02
Drugs
enlicitide
03
Conditions
familial hypercholesterolemia (FH)
Beyond the preview
Go deeper on CTR20254984.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20254984.